Trials / Completed
CompletedNCT01412021
Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Humira® for Subcutaneous Injection Special Investigation ( All-case Survey ) in Patients With Juvenile Idiopathic Arthritis Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 375 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 99 Years
- Healthy volunteers
- Not accepted
Summary
This study of Humira will be conducted to clarify the following with regard to the treatment of juvenile idiopathic arthritis affecting multiple joints with this drug: * Unknown adverse drug reactions (especially important adverse drug reactions) * Incidence and conditions of occurrence of adverse reactions in the clinical setting * Factors that may affect the safety and effectiveness of Humira
Conditions
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2018-04-02
- Completion
- 2018-04-02
- First posted
- 2011-08-08
- Last updated
- 2019-08-08
- Results posted
- 2019-08-08
Source: ClinicalTrials.gov record NCT01412021. Inclusion in this directory is not an endorsement.